HeGRI: A Novel Index of Serum Hepcidin Suppression in Relation to the Degree of Renal Dysfunction among β-Thalassemia Major Patients
Open Access
- 15 December 2021
- journal article
- research article
- Published by MDPI AG in Thalassemia Reports
- Vol. 12 (1) , 2-11
Abstract
Background: The progressive renal function inadequacy results in altered hepcidin metabolism due to a shifting of its renal elimination, which consequently affects enteric iron absorption and iron stores’ availability. This study aimed to investigate and correlate renal function, iron status, and hepcidin in patients with β-thalassemia major through a novel index. Methods: In this 1:1 case–control study, serum hepcidin, serum ferritin, iron study, hematological and renal function parameters were compared between 60 β-thalassemia major patients with iron overload and 61 healthy individuals (2–30 years old). Results: The concentrations of serum hepcidin (21.898 vs. 9.941 ng/mL; p < 0.001) and eGFR (179.71 vs. 132.95; p < 0.001) were significantly higher in β-thalassemia major patients compared to the controls. The serum hepcidin levels decreased with increasing levels of total iron-binding capacity (TIBC; β = −0.442; p = 0.024), transferrin saturation (β = −0.343; p = 0.023), serum creatinine (β = −0.625; p = 0.0030), and eGFR (β = −0.496; p = 0.011). The mean hepcidin/ferritin ratio was significantly lower in the β-thalassemia major cases (0.0069 vs. 0.3970; p < 0.001). The novel hepcidin/eGFR ratio index (HeGRI) was significantly higher in the patient group compared to controls (0.12 vs. 0.09; p = 0.031), respectively. Conclusions: These results suggest that HeGRI could be a potential index of the appropriateness of serum hepcidin suppression associated with the degree of renal dysfunction among β-thalassemia major patients.Keywords
This publication has 31 references indexed in Scilit:
- Hepcidin as a therapeutic tool to limit iron overload and improve anemia in β-thalassemic miceJournal of Clinical Investigation, 2010
- Hepcidin in β‐thalassemiaAnnals of the New York Academy of Sciences, 2010
- Hepcidin—A Potential Novel Biomarker for Iron Status in Chronic Kidney DiseaseClinical Journal of the American Society of Nephrology, 2009
- Plasma hepcidin levels are elevated but responsive to erythropoietin therapy in renal diseaseKidney International, 2009
- Advances in Quantitative Hepcidin Measurements by Time-of-Flight Mass SpectrometryPLOS ONE, 2008
- Regulation of hepcidin: Insights from biochemical analyses on human serum samplesBlood Cells, Molecules, and Diseases, 2008
- Association of Prohepcidin and Hepcidin-25 with Erythropoietin Response and Ferritin in Hemodialysis PatientsAmerican Journal of Nephrology, 2007
- Liver iron concentrations and urinary hepcidin in -thalassemiaHaematologica, 2007
- Urinary hepcidin in congenital chronic anemiasPediatric Blood & Cancer, 2005
- Hepcidin in iron overload disordersBlood, 2005